+ 7 (495) 684-04-00

Friday Investment Talk: Biotech, 2022 Forecast, M&A, Fusion Energy

Biotech indexes are not created equally. XBI is an equal weighted smaller cap index, while IBB is market cap with large weightings in COVID vaccine producers. Their results were very divergent in 2021.

Markets have grown substantially in 2021 on the back of loose monetary and fiscal policy in the US (and around the world). This is likely to propel markets higher still in 2022, although the trajectory of growth is likely to be more volatile with a change in the Feds Policy to more hawkish.

M&A activity is likely to strengthen in 2022, specifically in the biotech sector as large pharmaceutical companies look for new products from the many IPOs in 2021.

Fusion Energy made the headlines again this week and now is getting much more interest from investors. Two companies look interesting from a technical standpoint as they recently broke out to relative highs.

Join us live on Facebook Fridays @ 9PM Moscow

Subscribe

Scroll to Top